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We used positron emission tomography (PET) to measure brain
activity in healthy control subjects and unmedicated patients
with schizophrenia. Subjects were scanned in the context of a
combined psychological and pharmacological challenge, and
we examined the effects of apomorphine, a drug acting on
dopamine receptors, on brain systems engaged by a paced
verbal fluency task. This factorial design enabled comparison of
control subjects and schizophrenics in terms of the activations
engendered by the cognitive task and the pharmacological
challenge and the interaction of the two. We report a failure of
cognitive task-related activation in anterior cingulate cortex and
of task-related deactivation in the left superior temporal gyrus
in the schizophrenic subjects. Compared with controls, the
impaired cingulate activation was significantly reversed by apo-
morphine. Additionally, there was a trend for the abnormal
fronto-temporal pattern of activation in schizophrenic subjects
to be normalized by the drug. Overall, in schizophrenic subjects
the effect of apomorphine, which we interpret in terms of a net
dopaminergic antagonism, was to modify the brain activity,
making the pattern more akin to that seen in control subjects.
The results indicate both a regionally specific abnormality of
brain function in schizophrenia and an abnormal pattern of
fronto-temporal interactions.
Key words: PET; schizophrenia; apomorphine; verbal fluency;
fronto-temporal interaction
Schizophrenia is a psychotic illness characterized by an early age
of onset, symptoms such as delusions, hallucinations, disordered
thinking, and impoverished action and, often, a chronic, deterio-
rating course (American Psychiatry Association, 1987). The un-
derlying pathophysiology is unknown. A functional abnormality is
suggested by a relapsing and remitting course, fluctuations in
symptoms, and response to pharmacological interventions. The
clinical phenomena in schizophrenia contrast with the circum-
scribed deficits seen in classical neuropsychological disorders after
discrete brain lesions (Frith, 1992). The diversity of symptoms in
schizophrenia makes it unlikely that the pathophysiology can be
accounted for by localized brain dysfunction. The dynamic nature
of the clinical picture is strongly indicative of an abnormality,
rather than an absence, of function.
Two general theoretical approaches to understanding higher brain
function emphasize functional segregation and functional integra-
tion, respectively. In the former, specific cognitive processes or op-
erations are localized to discrete anatomical modules (Phillips et al.,
1984). In the latter, cognitive processes are emergent properties of
interconnected, although anatomically separate, modules (Tononi et
al., 1992). Although there is considerable understanding of segre-
gated function, the processes underlying functional integration are a
matter of debate (Engel et al., 1992; Tononi et al., 1994). The
majority of neurological research in schizophrenia has been predi-
cated on a segregationist perspective. However, one important his-
torical view of the pathophysiology of the psychoses has emphasized
that a disorder of integrative function could provide the mechanistic
basis for the observed psychological dysfunction (Wernicke, 1906). A
splitting or disintegration of psychological function was emphasized
in the earliest phenomenological formulations of schizophrenia, and
the concept of a split is, of course, inherent in the name itself
(Bleuler, 1987).
Little is known regarding the primary pathophysiology of
schizophrenia. However, the suggestion of a dopaminergic abnor-
mality (Randrup and Munkvad, 1972) remains central and is
supported by evidence from the psychosis-inducing effects of
dopamine agonists (Davidson et al., 1987) and by the antipsy-
chotic effects of dopamine antagonists (Creese et al., 1976; See-
man et al., 1976; Johnstone et al., 1978). Direct evidence for an
abnormality in dopamine function has been lacking, and in vivo,
quantitative, PET studies of dopamine receptor numbers have
been inconclusive (Wong et al., 1986; Farde et al., 1988, 1990).
However, functional imaging provides evidence of increased do-
pamine function in schizophrenic patients (Wong et al., 1986;
Hietala et al., 1995) coupled with complementary evidence of
increased central dopa decarboxylase activity (Reith et al., 1994;
Hietala et al., 1995).
Primate studies suggest that the functional effects of dopamine
are most appropriately studied in relation to its regulatory role on
cognitive functions mediated by the prefrontal cortex (Goldman-
Rakic et al., 1992). Human functional imaging has provided
parallel evidence for dopamine regulation of prefrontal cortex
function (Friston et al., 1991; Grasby et al., 1992a,b). We there-
fore chose to study dopamine function in schizophrenic patients in
the context of a task-related prefrontal activation based on a
combined psychological and pharmacological manipulation. Pre-
liminary data from the current experiment, indicating a regional
dysfunction in the anterior cingulate cortex and its modulation by
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a dopamine perturbation, have been the subject of a previous
short report (Dolan et al., 1995). In this report, we provide a more
extended account of the findings and present evidence of a dis-
ruption of integrative functions in acute unmedicated schizo-
phrenic patients.
MATERIALS AND METHODS
Twelve right-handed subjects who met DSM-III-R criteria for schizo-
phrenia were recruited from hospitals, outpatient departments, and gen-
eral practitioners in London. Their mean age was 26 6 7 years, and they
had a mean duration of illness (as estimated from personal interview,
interviews with relatives, and medical records) of 4.3 6 6 years. All of the
patients had been free of neuroleptic medication for at least 6 months
and, of the 12, 9 were neuroleptic-naive). Twelve healthy, age-matched
control subjects were recruited through advertisement. None had any
past history of psychiatric or neurological illness. The study was approved
by the local hospital ethics committee and the Administration of Radio-
active Substances Advisory Committee (UK; ARSAC).
All subjects underwent six measurements of brain activity over a 1.5 hr
period at the MRC Cyclotron Unit, Hammersmith hospital. Scans were
obtained using a CTI model 953B PET Scanner (CTI, Knoxville, TN)
with collimating septa retracted. Volunteers received a 2 min intravenous
infusion of H2
15O at a concentration of 55 MBq/ml and a flow rate of 10
ml/min through a forearm cannula. Scans were acquired over a 165 sec
period. All measurements were corrected for attenuation by transmission
scans.
Psychological tasks. During three of the PET measurements, subjects
were required to perform a paced orthographic verbal fluency task. A
chosen letter was repeated by the experimenter at a rate of once per 5 sec.
Subjects were required to produce verbally a word beginning with that
letter for each repetition. If a subject was no longer able to produce a
response for a given letter, he was instructed to say “pass” and the
experimenter switched to a different letter. The control condition, also
performed three times, alternating with the experimental condition, was
a paced word repetition task at a rate of one item per 5 sec and, therefore,
involved the same number and frequency of cues and responses as the
verbal fluency task.
Pharmacological challenge. After the second PET scan, six of the
subjects from each of the two groups (the schizophrenic and the control
groups) were given apomorphine (10 mg/kg, s.c.). After another 10 min,
scanning was resumed and the last four scans were obtained. The other
six subjects in each group were given a placebo subcutaneous injection
(water) after their second scan. The experimental design is summarized in
Figure 1.
Data analysis. The data were analyzed with statistical parametric map-
ping (using SPM95 software from the Wellcome Department of Cognitive
Neurology, London, UK) implemented in Matlab (Mathworks, Sherborn,
MA). Statistical parametric mapping combines the general linear model
(to create the statistical parametric map or SPM) and the theory of
Gaussian fields to make statistical inferences about regional effects (Fris-
ton et al., 1995).
In brief, the scans from each subject were realigned using the first scan
as reference (Friston et al., 1995). After realignment, all images were
transformed into a standard space (Talairach and Tournoux, 1988). This
normalizing spatial transformation matches each scan to a reference
template image that already conforms to the standard space (Friston et
al., 1996). As a final preprocessing step, the images were smoothed using
an isotropic Gaussian kernel (FWHM 12 mm). The condition, subject,
and covariate effects were estimated according to the general linear
model at each voxel (Friston et al., 1995). To test hypotheses about
regionally specific condition effects, the estimates were compared using
linear compounds or contrasts. The resulting set of voxel values for each
contrast constitutes a statistical parametric map of the t statistic, SPMt.
The SPMt were transformed to the unit normal distribution (SPMZ) and
thresholded at p 5 0.001 uncorrected for multiple comparisons.
RESULTS
Verbal fluency data
The task was not designed to test the subjects’ performance but,
rather, to ensure that all subjects were attempting the task
throughout the scanning period. Despite pacing, schizophrenic
subjects were slightly slower than control subjects, producing
fewer responses during the scanning time. However, these differ-
ences were nonsignificant. Similarly, schizophrenic subjects
tended to produce more “pass” responses, but these differences
were also not significant on t testing. Performance within and
across groups was not significantly influenced by apomorphine
injection. Performance figures are summarized in Table 1.
PET results
Verbal fluency activations in control and schizophrenic subjects
To examine activations associated with the verbal fluency task, we
restricted the analysis to the nonapomorphine scans because a
cognitive task-associated activation in the presence of apomor-
phine would incorporate, to some extent, an interaction with the
drug. In the control subjects, the verbal fluency task was associ-
ated with activation of the following areas: the prefrontal cortex
bilaterally, the anterior cingulate cortex, and thalamic/subtha-
lamic regions. These results are presented as an SPM (Fig. 2a)
and summarized in Table 2. In the schizophrenic subjects, there
Figure 1. Diagrammatic representation of the study design. Each subject
underwent 6 scans. Scans 1, 3, and 5 correspond to the verbal fluency task,
whereas Scans 2, 4, and 6 correspond to the control word repetition task.
After scan 2, each subject received either apomorphine or placebo. Thus,
this constituted a 3 3 2 3 3 split-plot design.
Table 1.
a. Performance (average number of words produced during scan)
Preinjection Postapomorphine Postplacebo
Schizophrenic
subjects 23.5 (8.8) 26 (6.6) 24.9 (10)
Control
subjects 30.8 (1.2) 32.3 (0.9) 31.8 (0.7)
b. Average number of “passes” during scan
Preinjection Postapomorphine Postplacebo
Schizophrenic
subjects 2.3 (2) 1.1 (1.1) 0.8 (0.8)
Control
subjects 0.7 (1) 0.6 (0.4) 2 (2.7)
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was also task-associated activation in the prefrontal cortex bilat-
erally and the anterior cingulate gyrus. In addition, activations
were seen in the left inferior parietal lobe, the left superior
temporal gyrus, and the posterior cingulate gyrus. These results
are summarized in Figure 2b and Table 2.
Verbal fluency deactivations in control and
schizophrenic subjects
Again, the analyses of the cognitive task effects were restricted to
nonapomorphine scans to avoid effects resulting from drug inter-
actions. In the control subjects, there were relative decreases in
rCBF in the fluency compared to the control condition centered
on the superior temporal gyri bilaterally and the posterior cingu-
late gyrus (Table 3). Likewise, in the same comparison the schizo-
phrenic subjects showed decreases in the superior temporal gyrus
bilaterally (far less spatially extensive than those seen in controls
with some areas of activation) and in the posterior and midcingu-







Left superior temporal gyrus 244, 226, 12 6.2
(BA 22/42) 248, 214, 8 5.8
246, 234, 16 5
Right superior temporal gyrus
(BA 22/42)
50, 212, 12 5.3
46, 220, 12 4.9
Posterior cingulate gyrus (BA 29/30) 2,252, 8 4
Schizophrenic subjects
Left superior temporal/inferior parietal
gyrus (BA 22/40)
244, 212, 8 4.6
250, 228, 20 4.2
Left superior temporal gyrus
(BA 22/40)
50, 218, 8 3.8
42, 222, 8 3.2
Posterior cingulate gyrus (BA 29/30) 6,252, 8 4.9
Cingulate gyrus (MID???) BA 24 2,210, 40 5.3
Right middle frontal gyrus (BA 6/8) 40, 8, 44 5.2
Left fusiform gyrus (BA 18) 228, 270, 28 4.3
a Talairach and Tournoux, 1988.
Figure 2. Statistical parametric maps (SPMs) showing brain regions
activated in the verbal fluency task relative to the control task. a, Control
subjects. b, Schizophrenic subjects. Areas of significant ( p , 0.001)
activation are shown in black within a representation of a standard brain
space (Talairach and Tournoux, 1988). Views are from the right (sagittal),
behind (coronal), and above (transverse). Transverse slices are labeled to
show the main areas activated (L. PFC and R. PFC: left and right
prefrontal cortex, respectively; Ant. Cing.: anterior cingulate gyrus).







Left anterior cingulate (BA 24/32) 210, 12, 36 7.2
24, 16, 24 6.6
212, 26, 28 5.8
Right inferior and medial frontal gyri
(BA 45/46)
30, 20, 4 5.4
26, 40, 28 5.2
Left inferior and medial frontal gyri
(BA 44/45/46/9)
252, 4, 28 4.6
242, 30, 32 3.2
248, 34, 16 3.1
Left subthalamic regions 24, 218, 24 3.8
Right subthalamic regions 4, 216, 0 3.2
Schizophrenic subjects
Left anterior cingulate (BA 32) 212, 10, 44 6.5
210, 30, 28 6.1
Right inferior and medial frontal gyri
(BA 44/45/46/9)
28, 22, 4 6.7
24, 38, 24 4.9
26, 38, 16 4.9
Left inferior and medial frontal gyri
(BA 44/45/46/9)
238, 0, 28 5.1
252, 12, 20 4.4
248, 14, 4 4.2
248, 14, 32 3.6
Left inferior parietal lobe (BA 40) 232, 256, 32 4.3
Posterior cingulate gyrus (BA 23/31) 216, 230, 32 4.1
Left superior temporal gyrus (BA 22) 238, 228, 4 4
a Scans performed in the presence of apomorphine were excluded.
b Talairach and Tournoux, 1988.
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late gyrus, the right middle frontal gyrus, and the left fusiform
gyrus (Table 3).
Group 3 task interactions
Group differences in cognitive task-related activations and deac-
tivations were determined in all nonapomorphine scans. The
group comparison revealed two critical differences in the form of
a relative failure of activation in schizophrenia in the anterior
cingulate cortex and a relative failure of deactivation in schizo-
phrenia in the left superior temporal gyrus and the left inferior
parietal lobe (see Fig. 3b, Table 4). Although the focus of im-
paired cingulate activation is on the right, the spatial resolution of
our technique does not allow a strong statement regarding later-
ality because of its close proximity to the midline. Additionally, at
a reduced level of significance, the failure of activation extends to
the left. The terms “activation” and “deactivation” are used here
in the functional neuroimaging sense and are not equivalent to
excitation and inhibition in the neurophysiological sense.
Apomorphine/cognitive-task interactions
In this analysis, the functional effects of apomorphine are most
appropriately framed in the context of its modulatory influences,
i.e., effects on a task-induced activation. The critical question is
whether there were task-induced activations that were modulated
(either attenuated or augmented) by apomorphine. Therefore,
the patterns of predrug activations and deactivations were com-
pared to those occurring postdrug both within and between
groups. Pre- and postplacebo scans were included in the analysis,
as above, to remove order effects (i.e., we looked for a three-way
interaction relative to placebo). There were no significant modu-
lations of task-related activity in the control subjects. In the
schizophrenic group, an apomorphine augmentation of the verbal
fluency activation was observed in the anterior cingulate cortex
and, at a lower threshold, in the prefrontal cortex bilaterally (see
Table 5).
A between-group comparison of the apomorphine-related aug-
mentations was constrained to the subset of voxels identified by the
analysis differential verbal fluency activations between the two
groups. This preselection represents a test of two independent hy-
potheses: (1) the area is differentially activated in schizophrenia; and
(2) this activation is modulated by apomorphine. The procedure
combines the outcome of two orthogonal sets of contrasts to yield a
SPM in which the statistical significance represents the joint proba-
bility of a type I error for the two sets of contrasts. In the present
case, the contrasts were each thresholded at p , 0.01 and regions
containing voxels in which apomorphine-related augmentations
(schizophrenic vs controls) occurred at conjoint significance level of
p , 0.0001 (uncorrected) were considered to be reliable. This com-
parison showed that there is an augmentation in the task-related
anterior cingulate activation that is significantly greater in schizo-
phrenic subjects (see Table 5, Fig. 4).
Finally, there was an attenuation of task-related activity in the
left superior/middle temporal gyrus in the schizophrenic group;
postapomorphine, which failed to reach significance at our pre-
determined threshold, was significant at p , 0.015 (uncorrected).
This finding is presented in Figure 5.
DISCUSSION
Functional imaging-based approaches to schizophrenia have pri-
marily emphasized segregated or regional brain dysfunction
Figure 3. SPMs presented as in Figure 2. a, Brain regions in which there
is a significant failure of activation in association with performance of the
verbal fluency task. The single area seen is the anterior cingulate gyrus. b,
Brain regions in which there is a significant failure of deactivation in
association with performance of the verbal fluency task. The main area
seen is the superior temporal gyrus. There is also a smaller area of
significant difference above it in the inferior parietal lobe.






Relative failures of activation in schizophrenia
Anterior cingulate gyrus (BA 24/32) 24, 26, 32 4.7
6, 16, 28 4.4
6, 6, 28 4.2
8, 32, 16 3.3
Relative failures of deactivation in schizophrenia
Left superior temporal gyrus 238, 228, 8 4.8
(BA 22/40) 252, 224, 8 3.7
256, 218, 12 3.7
Left inferior parietal lobe (BA 39/40) 232, 256, 32 3.6
a Talairach and Tournoux, 1988.
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(Chua and McKenna, 1995). There is evidence that regional
dysfunctions, such as hypofrontality and impaired frontal activa-
tion (Berman et al., 1988; Weinberger et al., 1988), are not
invariant findings, suggesting that they primarily reflect the cur-
rent mental state rather than fundamental aspects of the disease
process (Liddle et al., 1992; Dolan et al., 1993). Modification of
task requirements can result in similar patterns of activation in
schizophrenic patients and control subjects (Frith et al., 1995). An
approach to the analysis of functional imaging data that empha-
sizes neural integration, based on measures of functional connec-
tivity, has, furthermore, implicated a dysfunction of large-scale
neuronal interactions, as evidenced by a disruption of fronto-
temporal interactions, in schizophrenia (Friston et al., 1994; Fris-
ton and Frith, 1995).
Our findings indicate both segregated and integrative dysfunc-
tion. A failure of cognitive task-related activation in the anterior
cingulate cortex in the schizophrenic patients, and the modulation
of this dysfunction by a dopaminergic perturbation, suggested a
segregated abnormality. The absence of the normal reciprocal
interaction between the prefrontal and the superior temporal
cortex in schizophrenia, i.e., failure of task-related deactivation of
the superior temporal gyrus in the schizophrenic group, can be
interpreted within the context of impaired functional integration.
Comparison of verbal fluency task-related activity
across groups
Control subjects showed activations in anterior cingulate and
dorsolateral prefrontal cortex bilaterally with reciprocal deactiva-
tions in superior temporal and posterior cingulate cortex. Under
the verbal fluency condition, schizophrenic patients showed a
qualitatively similar pattern, as has been reported in chronic
schizophrenic subjects using the same tasks (Frith et al., 1995). A
formal comparison of the groups indicated a significant failure of
activation of the anterior cingulate cortex in schizophrenic pa-
tients (Fig. 3a). This failure supports other functional imaging
evidence of an anterior cingulate abnormality in schizophrenia
(Andreasen et al., 1992; Liddle et al., 1992; Tamminga et al., 1992;
Berman et al., 1995). Frith et al. (1995), using an identical para-
digm to the present study, failed to find a difference in anterior
cingulate activation between control and chronic schizophrenic
subjects. However, the latter patients were all receiving regular
doses of dopamine-blocking medication, which suggests that task-
related cingulate activation in schizophrenia is dependent on the
functional state of dopamine inputs (see below).
Activation of the anterior cingulate is a common finding in PET
studies (Frith et al., 1991a,b; Fletcher et al., 1995) engaging
selective attention to a stimulus or task and the inhibition of
inappropriate, competing responses. Lesions to this region are
also associated with a wide range of neuropsychological disorders
including aberrant social behavior, akinetic mutism, diminished
self-awareness, and depression (Devinsky et al., 1995). Its wide-
spread connections and functional heterogeneity (Devinsky et al.,
1995) suggest a role in the regulation or coordination of activity
within interconnected brain areas. For example, one study showed
that simultaneous performance of a distracting motor and mem-
ory task led to an increase in cingulate activation and a concurrent
decrease in left prefrontal activation (Fletcher et al., 1995). One
possibility is that an abnormality here leads to dysregulation of its
modulatory functions in the control of task-related cortico-
cortical interactions.
The finding of “normal” prefrontal activation is at variance with
some previous PET studies in schizophrenia (Weinberger et al.,
1986, 1988; Berman et al., 1995). It is in agreement, however, with
a study in which performance was optimized by pacing the task
(Frith et al., 1995). Although the issue of prefrontal function in
Figure 4. SPM presented as in Figures 2 and 3. This shows areas of
significant ( p , 0.005 conjoint significance) difference in drug–task inter-
action between the schizophrenic group and the control group. The area
in which there was an augmenting effect of the drug on the task related
activity occurring in schizophrenics compared to controls is shown to be




(x, y, z) Z score
Increases in cognitive task-related activity produced by apomorphine (schizophrenic subjects)
Anterior cingulate cortex (BA 24/32) 10, 20, 32 4.3
Right medial frontal gyrus (BA 9) 42, 26, 32 3.7
Left inferior frontal gyrus (BA 45) 232, 14, 20 3.7
Increases in cognitive task-related activity produced by apomorphine that significantly differ
between schizophrenic and control subjects
Anterior cingulate cortex (BA 24/32) 24, 210, 28 3.5
8, 18, 28 3.5
a Talairach and Tournoux, 1988.
Fletcher et al. • Dopamine and Cognitive Activation in Schizophrenia J. Neurosci., November 1, 1996, 16(21):7055–7062 7059
schizophrenia has yet to be resolved, there is increasing evidence
for a core pathology in the anterior cingulate cortex. Postmortem
studies have shown a loss of interneurons, with changes maximal
in layer II, a selective glutamatergic neuron loss, and altered
GABAA binding. It has been suggested, furthermore, that a loss
of the inhibitory interneurons in layer II results in increased
dopaminergic inputs to GABAergic neurons (Benes et al., 1986,
1987, 1991, 1992). Although the failure of anterior cingulate
activation is highlighted in the present study, the absence of a
prefrontal abnormality must be seen in the context of data indi-
cating abnormalities in prefrontal cortex structure (Selemon et al.,
1995) and function (Berman et al., 1986; Weinberger et al., 1986)
in schizophrenia. Our findings must be interpreted in the context
of the specific cognitive challenge used.
Dopamine and cortical function in schizophrenia
Our experimental design allowed investigation of in vivo dopami-
nergic effects on task-related neuronal activity. Apomorphine is a
nonselective dopamine agonist that has been used extensively as a
probe of dopaminergic function in both schizophrenic and de-
pressed patient populations (Meltzer et al., 1984). At low dosage,
its predominant effects are presynaptic, resulting in a net reduc-
tion of dopaminergic neurotransmission (Skirboll et al., 1979).
In the present study, there was no significant effect on task-
related changes in the comparison of apomorphine-treated with
placebo-treated control subjects. The absence of an apomorphine
effect on this activation can be reconciled with evidence that
dopaminergic modulation of prefrontal function is highly tuned
(Goldman-Rakic et al., 1992). One interpretation, therefore, is
that the perturbation of cortical dopamine input in controls was
insufficient to lead to an effect on regional physiology. We have
shown previously a regulatory effect of this dose (and a lower
dose) of apomorphine on prefrontal-mediated memory function
(Grasby et al., 1992b), a finding that, coupled with the present
finding, suggests that dopaminergic regulation of prefrontal func-
tion is highly specific and strongly task-dependent. For example, if
the current task engaged prefrontal cortex to a lesser degree than
in the previous study using a different paradigm (Grasby et al.,
1992b), then it may be less likely that a drug-induced modulation
of prefrontal activity would be seen.
When examined independently, the schizophrenic subjects, un-
like control subjects, revealed a significant effect of apomorphine
on task-related changes in rCBF in the anterior cingulate cortex.
This effect, an augmentation of activation, retained significance
when a direct comparison was made between the schizophrenic
and the control subjects in the same area where the schizophrenic
patients showed an abnormality in cognitive task-related activa-
tion. This finding (Fig. 4) indicates that the anterior cingulate
cortex functions abnormally in the context of the verbal fluency
task and that this area is hyper-responsive to a dopaminergic
perturbation. One interpretation of this finding is that schizophre-
nia is associated with a hyperdopaminergic state that exerts a net
inhibitory effect on task related activations. There is a broad range
of literature indicating the detrimental effects of dopamine on
cognitive function at the behavioral (Murphy et al., 1996) and
single cell (Williams and Goldman-Rakic, 1995) levels. Apomor-
phine, at the low dose used in the present study, has a predomi-
nantly presynaptic effect, resulting in a functional decrease in
dopamine neurotransmission (Brozoski et al., 1979), which could
account for the postdrug increase in task-related activity. Our
previous study of schizophrenic subjects receiving dopamine an-
Figure 5. Graphic representation of the
trend toward an augmentation of superi-
or/middle temporal lobe deactivations
produced by apomorphine. Equivalent
blood flow values have been averaged
from a voxel in the left superior/middle
temporal lobe and are shown pre- and
postapomorphine as labeled. As shown,
in the control group there is a preapo-
morphine task-related deactivation that
is hardly changed after administration of
the drug. In the schizophrenic group,
there is, in this area, an initial activation
that becomes a deactivation after drug
administration.
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tagonists found normal anterior cingulate activation in the context
of an identical verbal fluency task (Frith et al., 1995), consistent
with the suggestion that dopamine blockade can normalize cingu-
late function. It is noteworthy that apomorphine at a very similar
dosage has been shown to produce acute amelioration of schizo-
phrenic symptoms (Tamminga, 1978).
Task-related changes in the temporal cortex
Previous PET studies in normal volunteers have shown relative
deactivations in the lateral temporal regions bilaterally in associ-
ation with a variety of cognitive tasks that activate the prefrontal
cortex (Frith et al., 1991a; Grasby et al., 1993; Fletcher et al.,
1995). This finding was seen again in the control group under the
verbal fluency condition. The schizophrenic subjects showed a
significant failure of this deactivation (Fig. 3). Thus, there was a
disruption of normal task-related reciprocal pattern of activations
and deactivations in the schizophrenic patients. Such deactiva-
tions have been conceptualized as reflecting a complex phenom-
enon involving the integration of internally generated words or
actions into the perceptual domain (Frith, 1992; Friston and Frith,
1995). The finding of a failure of left temporal deactivation in the
schizophrenic group has been shown previously in three groups of
schizophrenic subjects (independent of their ability to perform the
task) (Frith et al., 1995), and it was suggested that it reflected an
abnormality of functional connectivity between prefrontal and
temporal structures (Friston et al., 1994). A disruption of func-
tional connectivity between the prefrontal and temporal cortex
may reflect a core pathophysiology in schizophrenia involving a
lack of integration across large scale neuronal networks. The
current study, in an unmedicated sample of patients, indicates that
this finding is not explicable on the basis of the effects of antipsy-
chotic medication.
Although not reaching our criterion for statistical significance,
the observation that apomorphine produces an augmentation of
the task-related temporal deactivation in the schizophrenic pa-
tients is interesting. Whether it reflects a direct effect of the
apomorphine on the temporal lobe or a “downstream” effect of
the anterior cingulate change (i.e., a normalization of task-related
cingulate activation influences the fronto-temporal interactions
resulting in a normalization of task-related deactivation) is un-
clear. Although highly speculative and bearing in mind the fact
that it is shown only as a trend in our data, there is some evidence
from nonhuman primate work that the anterior cingulate cortex
can modulate activity in other brain regions, notably the temporal
lobes (Muller-Preuss et al., 1980). However, the previous study
(on chronic, medicated patients) showed abnormal temporal de-
activation in the face of apparently normal cingulate activity
(Frith et al., 1995), so this interpretation is tentative.
In summary, we have demonstrated a functional abnormality in
the anterior cingulate cortex in schizophrenic subjects. Further, do-
paminergic perturbation results in an augmentation of task-related
activation in this region and a trend toward a normalization of
deactivation in the temporal lobe. Although the data must be treated
as preliminary, they do suggest that schizophrenia may be associated
with both segregated (anterior cingulate) and integrated (fronto-
temporal) abnormalities. Furthermore, our observation that
apomorphine-related reversal of the segregated abnormality is asso-
ciated with a trend toward normalization of impaired temporal
deactivation fuels our speculation that the abnormality of brain
integration in schizophrenia may be caused by a segregated dysfunc-
tion in the anterior cingulate region, the functions of which involve
modulation of cortico-cortical interactions.
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